ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SNG Synairgen Plc

4.52
-0.235 (-4.94%)
24 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.235 -4.94% 4.52 4.35 4.69 4.75 4.36 4.75 212,429 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.50 9.58M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.76p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.58 million. Synairgen has a price to earnings ratio (PE ratio) of -0.50.

Synairgen Share Discussion Threads

Showing 5801 to 5824 of 99175 messages
Chat Pages: Latest  235  234  233  232  231  230  229  228  227  226  225  224  Older
DateSubjectAuthorDiscuss
30/4/2020
16:42
https://twitter.com/share_talk/status/1255883982027309057?s=21
paradise city
30/4/2020
16:34
Slinkyj
30 Apr '20 - 13:29 - 5685 of 5741


It has to, as this is better news than we have had so far, and we are very much closer to results than before. People just waiting for a little drop again. Back up before close mark my words.

= = = =

Still want us to "mark your words"?

801710245
30/4/2020
16:34
See what auction brings.
cambradjones
30/4/2020
16:33
Couldnt get 10K buy though in last 5 mins
141jaffa
30/4/2020
16:31
Disappointing last 15mins I must say, but it's blue Friday tomorrow ( to follow blue Thurs !!! ).
cambradjones
30/4/2020
16:29
I see people digesting the news and another positive day tomorrow
d1nga
30/4/2020
16:28
As no further news is expected tomorrow this looks like drifting back below 55p again it seems unfortunately
tburns
30/4/2020
16:12
Whoop! Another rise on that due me thinks
slinkyj
30/4/2020
16:05
https://twitter.com/anksMallys/status/1255861436682833920?s=19Anyone see that?
idle jack
30/4/2020
15:44
Thanks. Not the first time I have done that.
vitec
30/4/2020
15:43
I do the same. Not sandy.lol.
cambradjones
30/4/2020
15:43
Wrong thread vitec.I do the sandy jumping from one BB to another.
cambradjones
30/4/2020
15:37
ebomber where is the narrative that L3 is on fire and that we can expect huge buy orders?
vitec
30/4/2020
15:27
Thought we could have finished 90 on news filtering through
bobaxe1
30/4/2020
15:25
Interesting that the Oxford vaccine began testing 1100 candidates last week.If that stage passes muster they are the going to start a 5000!!!! person trial to see it def works. And they expect the results of that by end of MAY ???Good luck with accomplishing that in that time frame !
cambradjones
30/4/2020
15:19
Hi Telbap - you good?
toffeeman
30/4/2020
15:17
MdChand - yes I saw that and thought

"They have got to be joking, that is far too complex to work in practice"

It really does not compute and I humbly suggest that it will never happen.

toffeeman
30/4/2020
15:16
Already known I'm sure....Prof Tom Wilkonson Chief Investigator of trial....and clinical lead on ACCORD with leading government partners..... https://www.theguardian.com/world/2020/mar/18/uk-coronavirus-patients-trial-experimental-lung-drug-synairgen-cureTom Wilkinson, a professor of respiratory medicine at the University of Southampton and the trial's chief investigator.https://www.southampton.ac.uk/news/2020/04/accord-covid-trial.pageACCORD (ACcelerating COVID-19 dRug Development) collaborative of leading UK doctors and scientists, industry and government partners.ACCORD clinical academic lead Professor Tom Wilkinson.
idle jack
30/4/2020
15:12
Well, I was getting tempted to top slice, but no chance now, even if this somehow fails to rally to new highs before results. I agree with those who are a little surprised it has not already exploded, but of no consequence and just kept in check by that persistent seller I guess.
lovewinshatelosses
30/4/2020
15:12
Finncap note out Near-term outlook. We still expect the results from the first part of the study(hospitalised patients who are not on ventilator treatment) to be released by June 2020.? Valuation. We reiterate our rNPV-based target price of 120p, of which c.80p relatesto the use of SNG001 in COVID-19 disease. The successful completion of the PhaseII study (SG016) would imply a rNPV of as much as c.£475m or a c.360p target price– suggesting a c.£360m (240p) uplift on the current estimated NPV
peanut100
30/4/2020
15:08
Most are delayed trades. All other volume is probably cancelling each other out. The MM's do not have much appetite for moving the share price in either direction.
vitec
30/4/2020
15:05
Don't know how we have flat lined for the last 40 mins with the volume currently going through.
cambradjones
30/4/2020
15:03
Very rarely does any share go up in a straight line. Retrace and then start to go up again is a healthy trading pattern albeit sometimes frustrating. The wider market will start to hear about SNG and the possibilities it will deliver to Covid 19 patients as well as other patients in need of assistance. Then the real fun will start to begin.
vitec
30/4/2020
14:54
Your chart here looks Uber set for another break upwards. Wish it would hurry up and get on with it!!
telbap
Chat Pages: Latest  235  234  233  232  231  230  229  228  227  226  225  224  Older

Your Recent History

Delayed Upgrade Clock